In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.
The RGV Desal project is a plan to build a massive seawater desalination plant on South Padre Island that will be capable of ...
Abbott Laboratories reported six-month data from its FlexPulse IDE trial showing its TactiFlex Duo Ablation Catheter achieved ...
Learn how the open-source DeepSeek V4 compares to ChatGPT in speed, pricing, and performance for developers building complex ...
New data on the pulsed-field ablation (PFA) device class debuts at HRS 2026 as the field catches the eye of several large ...
Though I’ve recommended that you avoid vibe coding for embedded systems, I’ve been using chatbots to help with my programming ...
Motif’s study primarily aims to validate the safety of its XCS system over a 12-month period following implantation.
Shares of Abbott Laboratories Inc. ABT moved higher in Monday's premarket session after the company unveiled new clinical ...
Visual Studio has never really been the lightweight option. It's not the tool you open just to tweak a config file or write a ...
Four late-breaking presentations at Heart Rhythm Society 2026 in Chicago highlight strong clinical evidence across Abbott's ...
AI’ into more and more places, Anthropic’s Model Context Protocol (MCP) has been adopted as the standard to connect LLMs ...
IDE supplement expands trial to the other primary standard-of-care chemotherapy for pancreatic cancer patients, alongside mFOLFIRINOX -- IDE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results